ESGMX
Price
$21.68
Change
+$0.03 (+0.14%)
Updated
Aug 27 closing price
Net Assets
962.98M
NPFCX
Price
$66.39
Change
+$0.02 (+0.03%)
Updated
Aug 27 closing price
Net Assets
158.54B
Interact to see
Advertisement

ESGMX vs NPFCX

Header iconESGMX vs NPFCX Comparison
Open Charts ESGMX vs NPFCXBanner chart's image
Mirova Global Megatrends A
Price$21.68
Change+$0.03 (+0.14%)
VolumeN/A
Net Assets962.98M
American Funds New Perspective C
Price$66.39
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets158.54B
ESGMX vs NPFCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ESGMX vs. NPFCX commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESGMX is a Buy and NPFCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 159B vs. ESGMX (963M). ESGMX pays higher dividends than NPFCX: ESGMX (0.11) vs NPFCX (0.00). ESGMX was incepted earlier than NPFCX: ESGMX (9 years) vs NPFCX (24 years). NPFCX (1.48) is less costly to investors than ESGMX (1.24). NPFCX is a more actively managed with annual turnover of: 24.00 vs. ESGMX (18.00). NPFCX has a lower initial minimum investment than ESGMX: NPFCX (250) vs ESGMX (2500). NPFCX annual gain was more profitable for investors over the last year : 10.56 vs. ESGMX (2.05). NPFCX return over 5 years is better than : 25.82 vs. ESGMX (23.52).
ESGMXNPFCXESGMX / NPFCX
Total Expense Ratio1.201.4881%
Annual Report Gross Expense Ratio1.241.4884%
Fund Existence9 years24 years-
Gain YTD9.00014.66361%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets963M159B1%
Annual Yield % from dividends0.110.00-
Returns for 1 year2.0510.5619%
Returns for 3 years43.6739.19111%
Returns for 5 years23.5225.8291%
Returns for 10 yearsN/A85.49-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NGVT57.400.41
+0.72%
Ingevity Corp
BWB16.450.07
+0.43%
Bridgewater Bancshares
GTBP1.14N/A
N/A
GT Biopharma
CCK99.83-0.96
-0.95%
Crown Holdings
CATO3.90-0.05
-1.27%
CATO Corp